Showing results (1861-1870 of 6,411) with videos related to
Sort By:
Pageof 642
World Journal of Urology|May 22, 2010
Modular therapy approach in metastatic castration-refractory prostate cancerB Walter, S Rogenhofer, M Vogelhuber, et al.World Journal of Urology|August 6, 2009
Elevated scrotal temperature, but not varicocele grade, reflects testicular oxidative stress-mediated apoptosisKoji Shiraishi, Hiroshi Takihara, Hideyasu MatsuyamaWorld Journal of Urology|July 25, 2009
Partners agree that the treatment of LUTS reduces patients' bother and improves their quality of life: prospective 12 years follow-up studySaid Fadel Mishriki, Samuel J S Grimsley, Ghulam Nabi, et al.World Journal of Urology|August 26, 2009
Place of overactive bladder in male lower urinary tract symptomsOsamu Yamaguchi, Ken Aikawa, Keiichi Shishido, et al.World Journal of Urology|September 19, 2009
New therapies for non-muscle-invasive bladder cancerEdmund Chiong, Kesavan EsuvaranathanWorld Journal of Urology|July 7, 2009
Laparoscopic ureteral reimplantation: prospective evaluation of medium-term results and current developmentsAli Serdar Gözen, Joanne Cresswell, Abdullah Erdem Canda, et al.World Journal of Urology|July 18, 2009
High risk NSGCT: case for surveillanceDavid Michael Kakiashvili, Alvaro Zuniga, Michael A S JewettWorld Journal of Urology|August 12, 2009
Thulium:YAG laser enucleation (VapoEnucleation) of the prostate: safety and durability during intermediate-term follow-upThorsten Bach, Christopher Netsch, Axel Haecker, et al.World Journal of Urology|March 10, 2011
Immediate renal Doppler ultrasonography findings (<24 h) and its association with graft survivalJavier Barba, Jorge Rioja, José Enrique Robles, et al.World Journal of Urology|April 24, 2020
Are 200 units of onabotulinumtoxin A sufficient for the suppression of neurogenic detrusor overactivity in individuals with established 300-unit botulinum toxin treatment? A retrospective cohort studyJörg Krebs, Jürgen Pannek, Franziska Rademacher, et al.Pageof 642